Jörg Cammenga
21 – 30 of 55
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
A new genetic tool to improve immune-compromised mouse models : Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines
- Contribution to journal › Article
-
Mark
Acute myeloid leukemia in very old patients
- Contribution to journal › Article
- 2017
-
Mark
Induction of the 5S RNP–Mdm2–p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia
- Contribution to journal › Article
-
Mark
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
- Contribution to journal › Article
-
Mark
Ataxia-pancytopenia syndrome with SAMD9L mutations
- Contribution to journal › Article
- 2016
-
Mark
Small molecule screen identifies differentiation-promoting compounds targeting genetically diverse acute myeloid leukaemia.
- Contribution to journal › Article
-
Mark
The european hematology association roadmap for european hematology research : A consensus document
- Contribution to journal › Article
-
Mark
Potential Pitfalls of the Mx1-Cre System : Implications for Experimental Modeling of Normal and Malignant Hematopoiesis
- Contribution to journal › Article
- 2015
-
Mark
Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia.
- Contribution to journal › Article
-
Mark
Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation.
- Contribution to journal › Article
